<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04987008</url>
  </required_header>
  <id_info>
    <org_study_id>Cohorte EPIC-FOP</org_study_id>
    <nct_id>NCT04987008</nct_id>
  </id_info>
  <brief_title>Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale</brief_title>
  <acronym>EPIC-FOPCohort</acronym>
  <official_title>Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale (29BRC21.0082)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      stroke's risk is increased in patients with pulmonary embolism and PFO compared to patients&#xD;
      without PFO. Does this increased risk persist years after pulmonary embolism ?&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      324 patients included in EPIC-FOP study (2009 to 2015) were followed annually to collect data&#xD;
      about the recurrence of VTE, cardiovascular events and treatments.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">May 18, 2021</start_date>
  <completion_date type="Anticipated">August 31, 2021</completion_date>
  <primary_completion_date type="Anticipated">August 31, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>stroke</measure>
    <time_frame>pulmonary embolism (2009 to 2015) to 2021</time_frame>
    <description>documented stroke</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>TIA or stroke</measure>
    <time_frame>pulmonary embolism (2009 to 2015) to 2021</time_frame>
    <description>documented TIA or stroke</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>death</measure>
    <time_frame>pulmonary embolism (2009 to 2015) to 2021</time_frame>
    <description>all deaths and cardiovascular deaths</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bleeding</measure>
    <time_frame>pulmonary embolism (2009 to 2015) to 2021</time_frame>
    <description>Major and clinically pertinent bleeding (ISTH classification)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>VTE</measure>
    <time_frame>pulmonary embolism (2009 to 2015) to 2021</time_frame>
    <description>recurrent VTE</description>
  </secondary_outcome>
  <enrollment type="Anticipated">53</enrollment>
  <condition>Foramen Ovale, Patent</condition>
  <eligibility>
    <study_pop>
      <textblock>
        53 of the 324 EPIC-FOP patients not followed in previous PE cohort&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients included in EPIC-FOP study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  refusal to participate&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_contact>
    <last_name>Emmanuelle LE MOIGNE</last_name>
    <phone>0298347344</phone>
    <email>emmanuelle.lemoigne@chu-brest.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>HIA</name>
      <address>
        <city>Brest</city>
        <zip>29600</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Marc Danguy des DÃ©serts</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHRU de Brest</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Emmanuelle LE MOIGNE</last_name>
    </contact>
  </location>
  <location>
    <facility>
      <name>CHIC de Quimper</name>
      <address>
        <city>Quimper</city>
        <zip>29000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Thierry JOSEPH</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2021</verification_date>
  <study_first_submitted>July 27, 2021</study_first_submitted>
  <study_first_submitted_qc>August 2, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">August 3, 2021</study_first_posted>
  <last_update_submitted>August 2, 2021</last_update_submitted>
  <last_update_submitted_qc>August 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">August 3, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>foramen ovale, patent</keyword>
  <keyword>stroke</keyword>
  <keyword>pulmonary embolism</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pulmonary Embolism</mesh_term>
    <mesh_term>Ischemic Stroke</mesh_term>
    <mesh_term>Embolism</mesh_term>
    <mesh_term>Foramen Ovale, Patent</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>All collected data that underlie results in a publication.</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_time_frame>Data will be available beginning three years and ending five years following the final study report completion.</ipd_time_frame>
    <ipd_access_criteria>Data access request will be reviewed by the internal committee of Brest University Hospital. Requestor will be required to sign and complete a data access agreement.</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

